Please assess the completion status of the following clinical trial:

Trial Title: A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam®

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The main criteria for inclusion in the study were as follows:~  * A diagnosis of primary antibody deficiency;~ * No lower or upper age limit (any age was eligible);~ * With stable disease and receiving immunoglobulin (IVIG or SCIG) therapy for at least six months prior to starting the study;~ * Written informed consent (patient/parent/guardian).~Exclusion Criteria:~-

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Subgam® (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).